- New state-of-the-art facility designed explicitly for gene and cell therapy development LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix SA emerged from stealth today as a technology innovation ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

THE STRUCTURE AND FUNCTION OF RECOMBINANT HUMANIZED TYPE III COLLAGEN AS WELL AS ITS RELATED PRODUCT approved by CHINA NMPa for COSMETICS USE (ADAPTED FROM THE AUTHORS’ PUBLICATION IN Biochemical and ...

Berg was awarded one-half of the Nobel Prize in Chemistry in 1980 for his work with recombinant DNA technology. A series of rodent experiments showed that even with abundant food and water, personal ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

insights from industryAmy ShengHead of CROSino Biological In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO program at Sino Biological US Inc., about current developments in the ...

In this GEN webinar, our expert speakers will present a case study demonstrating the exceptional properties and high-fidelity performance of ENFINIA Linear DNA.

His company, the Chiron Corporation, contributed important scientific discoveries toward treatments for H.I.V., hepatitis B, diabetes and more. By Trip Gabriel William J. Rutter, a scientist who ...

Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...